SLDB ▲ +3.4% - Solid Biosciences Inc. $SLDB - Solid Biosciences Announces European Commission Orphan Designation for SGT-212 and Continued Progress in the FALCON Trial in Friedreich’s Ataxia 26-OCT-2026 08:00 AM ET